FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,000 | -57.7% | 15,971 | -1.2% | 0.00% | – |
Q2 2023 | $78,000 | -17.0% | 16,171 | -2.9% | 0.00% | – |
Q1 2023 | $94,000 | -40.9% | 16,656 | +5.6% | 0.00% | – |
Q4 2022 | $159,000 | -59.3% | 15,775 | -9.7% | 0.00% | -100.0% |
Q3 2022 | $391,000 | +49.8% | 17,469 | +67.2% | 0.00% | 0.0% |
Q2 2022 | $261,000 | -63.4% | 10,450 | -43.1% | 0.00% | -50.0% |
Q1 2022 | $714,000 | -29.9% | 18,361 | +5.9% | 0.00% | 0.0% |
Q4 2021 | $1,019,000 | +30.8% | 17,345 | +31.8% | 0.00% | 0.0% |
Q3 2021 | $779,000 | -34.4% | 13,163 | -5.6% | 0.00% | -33.3% |
Q2 2021 | $1,188,000 | +118.8% | 13,950 | +112.9% | 0.00% | +50.0% |
Q1 2021 | $543,000 | – | 6,553 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |